Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
FINDEX Inc. ( (JP:3649) ) has shared an announcement.
FINDEX Inc. reported its preliminary results for product implementations as of December 31, 2024. The results highlight growth in user numbers across various medical software products, with significant increases noted for the Claio and DocuMaker software. This indicates a steady expansion in their market presence, particularly within university and general hospitals, potentially enhancing their industry positioning and stakeholder value.
More about FINDEX Inc.
FINDEX Inc. operates in the software industry, focusing on developing data management and document management software solutions. Its primary products include Claio, DocuMaker, C-Scan, PDI+ MoveBy, MapleNote, and REMORA, which are tailored for medical institutions such as hospitals and clinics, as well as solutions for local governments.
YTD Price Performance: 2.45%
Average Trading Volume: 41,089
Technical Sentiment Consensus Rating: Sell
Current Market Cap: Yen22.46B
For an in-depth examination of 3649 stock, go to TipRanks’ Stock Analysis page.